TipRanks
Aclaris Therapeutics (DE:8AT)
FRANKFURT:8AT
Germany Market
8AT
Aclaris Therapeutics
RESEARCH TOOLSreports

Aclaris Therapeutics (8AT) Income Statement

1 Followers

Aclaris Therapeutics Income Statement

Last quarter (Q2 2026), Aclaris Therapeutics's total revenue was $1.63M, a decrease of -8.33% from the same quarter last year. In Q2, Aclaris Therapeutics's net income was $-21.50M. See Aclaris Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 7.83M$ 18.72M$ 31.25M$ 29.75M$ 6.76M
Gross Profit
$ 5.74M$ 15.93M$ 13.17M$ 17.79M$ 2.05M
Operating Expenses
$ 82.11M$ 157.86M$ 110.53M$ 107.65M$ 91.77M
Depreciation and Amortization
$ 454.00K$ 807.00K$ 863.00K$ 797.00K$ 923.00K
EBITDA
$ -64.47M$ -51.72M$ -115.45M$ -84.36M$ -64.46M
Operating Income
$ -76.38M$ -141.93M$ -97.36M$ -89.85M$ -89.72M
Other Income/Expenses
$ 11.45M$ 9.87M$ 8.51M$ 2.95M$ -1.14M
Pretax Income
$ -64.92M$ -132.06M$ -88.85M$ -86.91M$ -90.86M
Net Income
$ -64.92M$ -132.06M$ -88.48M$ -86.91M$ -90.86M
Per Share Metrics
Basic EPS
$ -0.53$ -1.71$ -1.27$ -1.33$ -1.60
Diluted EPS
$ -0.53$ -1.71$ -1.27$ -1.33$ -1.60
Weighted Average Shares Outstanding
 122.66M 77.30M 69.81M 65.21M 56.73M
Weighted Average Shares Outstanding (Diluted)
 122.66M 77.30M 69.81M 65.21M 56.73M
Currency in USD

Aclaris Therapeutics Earnings and Revenue History